PURE Bioscience, Inc. filed its 10-K on Oct 28, 2022 for the period ending Jul 31, 2022. In this report its auditor, Weinberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.071 USD | +1.43% | +5.97% | -45.26% |
1st Jan change | Capi. | |
---|---|---|
-45.26% | 7.94M | |
+12.44% | 25.93B | |
+2.73% | 18.18B | |
-26.63% | 6.09B | |
+6.04% | 5.98B | |
-5.67% | 3.06B | |
+5.20% | 2.42B | |
-11.02% | 1.85B | |
+27.19% | 936M | |
-4.16% | 618M |
- Stock Market
- Equities
- PURE Stock
- News PURE Bioscience, Inc.
- PURE Bioscience, Inc. Auditor Raises 'Going Concern' Doubt